ObjectiveThe purpose of the study was to determine the effects of aprotinin on (1) renal function, (2) apoptosis and apoptotic signaling, and (3) the inflammatory response of the kidney after ischemia-reperfusion injury.MethodsMale rats underwent a sham procedure or left renal ischemia for 1 hour. Rats were divided into three groups and received no reperfusion, reperfusion for 1 hour, or reperfusion for 24 hours. The animals undergoing ischemia received saline solution alone or aprotinin (60,000 kIU/kg). At the end of the experiment, a sample for serum creatinine was taken and the left kidney was harvested. The kidney was analyzed for expression of tumor necrosis factor α, interleukin 1β, and interleukin 6 (enzyme-linked immunosorbent assay...
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure.Backgroun...
The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat....
Department of General Surgery, University of Maastricht, 6200 MD Maastricht, The Netherlands.Ischemi...
ObjectiveThe purpose of the study was to determine the effects of aprotinin on (1) renal function, (...
Background—Reperfusion injury of ischemic myocardium has been attributed to neutrophil infiltration,...
Bovine aprotinin, a reversible inhibitor of plasmin and kallikrein, has been clinically approved for...
Abstract Background Acute kidney injury is a severe complication following cardiopulmonary bypass (C...
Introduction: Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespr...
AbstractObjective: Early coronary reperfusion of the ischemic myocardium is a desired therapeutic go...
Objectives: This study aims to investigate the effects and molecular mechanisms of apigenin (ApI) on...
Background. Renal ischemia-reperfusion injury (IRI) is a major factor causing acute kidney injury (A...
Objectives: In addition to blood-sparing effects, aprotinin may have cardioprotective and anti-infla...
Background: Renal ischemiaereperfusion (I/R) injury is a major cause of acute kidney failure by mech...
Background: Aprotinin is a drug used to reduce postoperative bleeding in patients undergoing open he...
PubMed ID: 9489880Objective: The protective effect of aprotinin, which is a protease inhibitor, was ...
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure.Backgroun...
The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat....
Department of General Surgery, University of Maastricht, 6200 MD Maastricht, The Netherlands.Ischemi...
ObjectiveThe purpose of the study was to determine the effects of aprotinin on (1) renal function, (...
Background—Reperfusion injury of ischemic myocardium has been attributed to neutrophil infiltration,...
Bovine aprotinin, a reversible inhibitor of plasmin and kallikrein, has been clinically approved for...
Abstract Background Acute kidney injury is a severe complication following cardiopulmonary bypass (C...
Introduction: Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespr...
AbstractObjective: Early coronary reperfusion of the ischemic myocardium is a desired therapeutic go...
Objectives: This study aims to investigate the effects and molecular mechanisms of apigenin (ApI) on...
Background. Renal ischemia-reperfusion injury (IRI) is a major factor causing acute kidney injury (A...
Objectives: In addition to blood-sparing effects, aprotinin may have cardioprotective and anti-infla...
Background: Renal ischemiaereperfusion (I/R) injury is a major cause of acute kidney failure by mech...
Background: Aprotinin is a drug used to reduce postoperative bleeding in patients undergoing open he...
PubMed ID: 9489880Objective: The protective effect of aprotinin, which is a protease inhibitor, was ...
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure.Backgroun...
The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat....
Department of General Surgery, University of Maastricht, 6200 MD Maastricht, The Netherlands.Ischemi...